DB15277InvestigationalProtein Based Therapies
Gedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).
- Also known as
- MHAA4549A
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Gedivumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account